Cargando…
Targeting of the Cancer-Associated Fibroblast—T-Cell Axis in Solid Malignancies
The introduction of a wide range of immunotherapies in clinical practice has revolutionized the treatment of cancer in the last decade. The majority of these therapeutic modalities are centered on reinvigorating a tumor-reactive cytotoxic T-cell response. While impressive clinical successes are obta...
Autores principales: | Harryvan, Tom J., Verdegaal, Els M. E., Hardwick, James C. H., Hawinkels, Lukas J. A. C., van der Burg, Sjoerd H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912330/ https://www.ncbi.nlm.nih.gov/pubmed/31731701 http://dx.doi.org/10.3390/jcm8111989 |
Ejemplares similares
-
The ABCs of Antigen Presentation by Stromal Non-Professional Antigen-Presenting Cells
por: Harryvan, Tom J., et al.
Publicado: (2021) -
Fibroblast Subsets in Intestinal Homeostasis, Carcinogenesis, Tumor Progression, and Metastasis
por: Dang, Hao, et al.
Publicado: (2021) -
Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S
por: Harryvan, Tom J, et al.
Publicado: (2022) -
The Potential and Challenges of Exploiting the Vast But Dynamic Neoepitope Landscape for Immunotherapy
por: Verdegaal, Els M. E., et al.
Publicado: (2017) -
IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma
por: Melief, Sara M., et al.
Publicado: (2017)